NEW YORK, Nov. 3 (GenomeWeb News) - Amersham Biosciences has signed agreement to design a customized version of its Scierra Solutions laboratory workflow system for the Windber Research Institute, for use in Windber's clinical breast cancer project, the company said today.
Windber, of Windber, Pa., has already been using Scierra systems for gene expression, sequencing, genotyping, and proteomics. The new system ads the capability of ing information on patient histories, patient samples, and pathology, and being integrated with the company's genomics and proteomics data, according to both parties.
"This first of a kind advanced workflow system links clinical data and pathology information collected on patient samples with data from our research laboratories resulting in a comprehensive data warehouse that is unrivalle in breast cancer research, Richard Somiari, Chief Operating/Scientific Officer at the Windber Research Institute, said in a statement."
The parties did not disclose the financial terms of the agreement.